Genetic forms of nephrotic syndrome

Pediatric Nephrology

Volumn 19, Issue 12, 2004, Pages 1313-1318

  Niaudet, Patrick ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Congenital nephrotic syndrome; Focal segmental glomerulosclerosis; Nephrin; NPHS1; NPHS2; Podocin; WT1

Indexed keywords

NEPHRIN; PODOCIN; STEROID; WT1 PROTEIN;

ARTICLE; CHILD; COHORT ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; FOCAL GLOMERULOSCLEROSIS; GENE MUTATION; HUMAN; INHERITANCE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; NEPHROTIC SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; RECURRENCE RISK;

CHILD; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY TRANSPLANTATION; MEMBRANE PROTEINS; MUTATION; NEPHROTIC SYNDROME; PROTEINS; PROTEINURIA; RECURRENCE; WT1 PROTEINS;

EID: 8844274003     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-004-1676-9     Document Type: Article

References (51)

1. Pollak M (2002) Inherited podocytopathies: FSGS and nephrotic syndrome from a genetic viewpoint. J Am Soc Nephrol 13:3016-3023. 12444222
2. Antignac C (2002) Genetic models: Clues for understanding the pathogenesis of idiopathic nephrotic syndrome. J Clin Invest 109:447-449. 10.1172/JCI200215094, 1:CAS:528:DC%2BD38XhsVSktrs%3D, 11854315
3. Hallman N, Hjelt L, Ahvenainen EK (1956) Nephrotic syndrome in newborn and young infants. Ann Pediatr Fenn 2:227-241
4. Huttunen N-P (1976) Congenital nephrotic syndrome of Finnish type. Study of 75 cases. Arch Dis Child 51:344-348
5. Huttunen N-P, Rapola J, Vilska J, Hallman N (1980) Renal pathology in congenital nephrotic syndrome of Finnish type: A quantitative light microscopic study of 50 patients. Int J Pediatr Nephrol 1:10-16. 1:STN:280:Bi2B3M3psVU%3D, 7343522
6. Kestilä M, Lenkkeri U, Lamerdin J, McCready P, Putaala H, Ruotsalainen V, Morita T, Nissinen M, Herva R, Kashtan CE, Peltonen L, Holmberg C, Olsen A, Tryggvason K (1998) Positionally cloned gene for a novel glomerular protein-nephrin - is mutated in congenital nephrotic syndrome. Mol Cell 1:575-582. 10.1016/S1097-2765(00)80057-X, 1:CAS:528:DyaK1cXit1Gisbw%3D, 9660941
7. Lenkkeri U, Männikkö M, McCready P, Lamerdin J, Gribouval O, Niaudet P, Antignac CK, Kashtan CE, Homberg C, Olsen A, Kestila M, Tryggvason K (1999) Structure of the gene for congenital nephrotic syndrome of the Finnish type ( NPHS1 ) and characterization of mutations. Am J Hum Genet 64:51-61. 10.1086/302182, 1:CAS:528:DyaK1MXht1emu7c%3D, 9915943
8. Beltcheva O, Martin P, Lenkkeri U, Tryggvason K (2001) Mutation spectrum in the nephrin gene ( NPHS1 ) in congenital nephrotic syndrome. Hum Mutat 17:368-373. 10.1002/humu.1111, 1:CAS:528:DC%2BD3MXjvVCgu70%3D, 11317351
9. Fuchshuber A, Niaudet P, Gribouval O, Jean G, Gubler MC, Broyer M, Antignac C (1996) Congenital nephrotic syndrome of the Finnish type: linkage to the locus in a non-Finnish population. Pediatr Nephrol 10:135-138. 10.1007/s004670050081, 1:STN:280:BymB28jksFM%3D, 8703694
10. Gigante M, Monno F, Roberto R, Laforgia N, Assael MB, Livolti S, Caringella A, La Manna A, Masella L, Iolascon A (2002) Congenital nephrotic syndrome of the Finnish type in Italy: A molecular approach. J Nephrol 15:696-702
11. Koziell A, Grech V, Hussain S, Lee G, Lenkkeri U, Tryggvason K, Scambler P (2002) Genotype/phenotype correlations of NPHS1 and NPHS2 mutations in nephrotic syndrome advocate a functional inter-relationship in glomerular filtration. Hum Mol Genet 11:379-388. 10.1093/hmg/11.4.379, 1:CAS:528:DC%2BD38XitF2mtLc%3D, 11854170
12. Schultheiss M, Ruf RG, Mucha BE, Wiggins R, Fuchshuber A, Lichtenberger A, Hildebrandt F (2004) No evidence for genotype/phenotype correlation in NPHS1 and NPHS2 mutations. Pediatr Nephrol (in press)
13. Patrakka J, Kestila M, Wartiovaara J, Ruotsalainen V, Tissari P, Lenkkeri U, Mannikko M, Visapaa I, Holmberg C, Rapola J, Tryggvason K, Jalanko H (2000) Congenital nephrotic syndrome (NPHS1); features resulting from different mutations in Finnish patients. Kidney Int 58:972-980. 10.1046/j.1523-1755.2000.00254.x, 1:CAS:528:DC%2BD3cXmsleitrc%3D, 10972661
14. Fuchshuber A, Jean G, Gribouval O, Gubler MC, Broyer M, Beckmann JS, Niaudet P, Antignac C (1995) Mapping a gene ( SNR1 ) to chromosome 1q25-q31 in idiopathic nephrotic syndrome confirms a distinct entity of autosomal recessive nephrosis. Hum Mol Genet 4:2155-2158. 1:CAS:528:DyaK2MXpt1Oqurk%3D, 8589695
15. Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, Dahan K, Gubler MC, Niaudet P, Antignac C (2000) NPHS2 , encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 24:349-354. 10.1038/74166, 1:CAS:528:DC%2BD3cXisVCjsb4%3D, 10742096
16. Roselli S, Gribouval O, Boute N, Sich M, Benessy F, Attie T, Gubler MC, Antignac C (2002) Podocin localizes in the kidney to the slit diaphragm area. Am J Pathol 160:131-139. 1:CAS:528:DC%2BD38XnvFehtg%3D%3D, 11786407
17. Huber TB, Simons M, Hartleben B, Sernetz L, Schmidts M, Gundlech E, Saleem MA, Walz G, Benzing T (2003) Molecular basis of the functional podocin-nephrin complex: Mutations in the NPHS2 gene disrupt nephrin targeting to the lipid raft microdomains. Hum Mol Genet 12:3397-3405. 10.1093/hmg/ddg360, 1:CAS:528:DC%2BD3sXpsl2mtb4%3D, 14570703
18. Schwarz K, Simons M, Reiser J, Saleem MA, Faul C, Kriz W, Shaw AS, Holzman LB, Mundel P (2001) Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest 108:1621-1629. 10.1172/JCI200112849, 1:CAS:528:DC%2BD3MXovVCgs7g%3D, 11733557
19. Caridi G, Bertelli R, Di Duca M, Dagnino M, Emma F, Onetti Muda A, Scolari F, Miglietti N, Mazzucco G, Murer L, Carrea A, Massella L, Rizzoni G, Perfumo F, Ghiggeri GM (2003) Broadening the spectrum of diseases related to podocin mutations. J Am Soc Nephrol 14:1278-1286. 1:CAS:528:DC%2BD3sXislKjtLw%3D, 12707396
20. Ruf RG, Lichtenberger A, Karle SM, Haas JP, Anacleto FE, Schultheiss M, Zalewski I, Imm A, Ruf EM, Mucha B, Bagga A, Neuhaus T, Fuchshuber A, Bakkaloglu A, Hildebrandt F (2004) Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol 15:722-732
21. Weber S, Gribouval O, Esquivel EL, Morinière V, Tête MJ, Legendre C, Niaudet P, Antignac C (2004) NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int 66:571-579. 10.1111/j.1523-1755.2004.00776.x, 1:CAS:528:DC%2BD2cXmvVegsLw%3D, 15253708
22. Caridi G, Berdeli A, Dagnino M, Di Duca M, Mir S, Cura A, Ravazzolo R, Ghiggeri GM (2004) Infantile steroid-resistant nephrotic syndrome associated with double homozygous mutations of podocin. Am J Kidney Dis 43:727-732. 10.1053/j.ajkd.2003.12.034, 15042551
23. Tsukaguchi H, Sudhakar A, Cam Le T, Nguyen T, Yao J, Schwimmer JA, Schachter AD, Poch E, Abreu PF, Appel GB, Pereira AB, Kalluri R, Pollak MR (2002) NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. J Clin Invest 110:1659-1666. 10.1172/JCI200216242, 1:CAS:528:DC%2BD38Xptlars74%3D, 12464671
24. Roselli S, Moutkine I, Gribouval O, Benmerah A, Antignac C (2003) Plasma membrane targeting of podocin through classical exocytic pathway: Effect of NPHS2 mutations. Traffic 5:1-8
25. Pereira AC, Pereira AB, Mota GF, Cunha RS, Herkenhoff FL, Pollak MR, Mill JG, Krieger JE (2004) NPHS2 R229Q functional variant is associated with microalbuminuria in the general population. Kidney Int 65:1026-1030. 10.1111/j.1523-1755.2004.00479.x, 1:CAS:528:DC%2BD2cXitleksbw%3D, 14871423
26. Karle SM, Uetz B, Ronner V, Glaeser L, Hildebrandt F, Fuchshuber A (2002) Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome. J Am Soc Nephrol 13:388-393. 1:CAS:528:DC%2BD38XhtlWju74%3D, 11805166
27. Frishberg Y, Rinat C, Megged O, Shapira E, Feinstein S, Raas-Rothschild A (2002) Mutations in NPHS2 encoding podocin are a prevalent cause of steroid-resistant nephrotic syndrome among Israeli-Arab children. J Am Soc Nephrol 13:400-405. 1:CAS:528:DC%2BD38XhtlWju7w%3D, 11805168
28. Caridi G, Bertelli R, Carrea A, Di Duca M, Catarsi P, Artero M, Carraro M, Zennaro C, Candiano G, Musante L, Seri M, Ginevri F, Perfumo F, Ghiggeri GM (2001) Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. J Am Soc Nephrol 12:2742-2746. 1:CAS:528:DC%2BD38Xkt1Sk, 11729243
29. Reddy JC, Licht JD (1996) The WT1 Wilms' tumor suppressor gene: How much do we really know? Biochim Biophys Acta 1287:1-28. 10.1016/0304-419X(95)00014-7, 1:CAS:528:DyaK28XivFKkur4%3D, 8639704
30. Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteous D, Gosden C, Bard J, Buckler A, Pelletier J, Housman D (1990) The candidate Wilms' tumour gene is involved in genitourinary development. Nature 346:194-197. 10.1038/346194a0, 1:STN:280:By%2BA3cbpvFI%3D, 2164159
31. Habib R, Loirat C, Gubler MC, Niaudet P, Bensman A, Levy M, Broyer M (1985) The nephropathy associated with male pseudohermaphroditism and Wilms' tumor (Drash syndrome): A distinctive glomerular lesion, report of 10 cases. Clin Nephrol 24:269-278. 1:STN:280:BimD1c%2Fis1Y%3D, 3000666
32. Little M, Wells C (1997) A clinical overview of WT1 gene mutations. Hum Mutat 9:209-225. 10.1002/(SICI)1098-1004(1997)9:3<209::AID-HUMU2>3.0.CO;2-2, 1:CAS:528:DyaK2sXisFGgu74%3D
33. Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L (1991) Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67:437-447. 10.1016/0092-8674(91)90194-4, 1:CAS:528:DyaK3MXmsV2ntrc%3D, 1655284
34. Jeanpierre C, Béroud C, Niaudet P, Junien C (1998) Software and database for the analysis of mutations in the human WT1 gene. Nucleic Acids Res 26:273-277. 10.1093/nar/26.1.271
35. Jeanpierre C, Denamur E, Cabanis MO, Luce S, Cecille A, Elion J, Peuchmaur M, Loirat C, Niaudet P, Gubler MC, Junien C (1998) Identification of constitutional WT1 mutations in patients with isolated diffuse mesangial sclerosis (IDMS) and analysis of genotype-phenotype correlations using a computerized mutation database. Am J Hum Genet 62:824-833. 10.1086/301806, 1:CAS:528:DyaK1cXlvVahsrg%3D, 9529364
36. Yang Y, Jeanpierre C, Dressler GR, Lacoste M, Niaudet P, Gubler MC (1999) WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis. Am J Pathol 154:181-192. 1:CAS:528:DyaK1MXnsFGjug%3D%3D, 9916932
37. Dressler GR, Wilkinson JE, Rothenpieler UW, Patterson LT, Williams-Simons L, Westphal H (1993) Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities. Nature 362:65-67. 10.1038/362065a0, 1:CAS:528:DyaK3sXhvV2htrc%3D, 8383297
38. Frasier S, Bashore RA, Mosier HD (1964) Gonadoblastoma associated with pure gonadal dysgenesis in monozygotic twins. J Pediatr 64:740-745. 1:STN:280:CCuC3cnptl0%3D, 14149008
39. Moorthy AV, Chesney RW, Lubinsky M (1987) Chronic renal failure and XY gonadal dysgenesis: "Frasier" syndrome-a commentary on reported cases. Am J Med Genet [Suppl 3]:297-302
40. Barbaux S, Niaudet P, Gubler MC, Grunfeld JP, Jaubert F, Kuttenn F, Fekete CN, Souleyreau-Therville N, Thibaud E, Fellous M, McElreavey K (1997) Donor splice site mutations in the WT1 gene are responsible for Frasier syndrome. Nat Genet 17:467-469. 1:CAS:528:DyaK2sXnvFWrsrY%3D, 9398852
41. Kikuchi H, Takata A, Akasaka Y, Fukuzawa R, Yoneyama H, Kurosawa Y, Honda M, Kamiyama Y, Hata J (1998) Do intronic mutations affecting splicing of WT1 exon 9 cause Frasier syndrome ? J Med Genet 35:45-48. 1:CAS:528:DyaK1cXpslaquw%3D%3D, 9475094
42. Klamt B, Koziell A, Poulat F, Wieacker P, Scambler P, Berta P, Gessler M (1998) Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1+/-KTS splice isoforms. Hum Mol Genet 7:709-714. 10.1093/hmg/7.4.709, 1:CAS:528:DyaK1cXisVCjur0%3D, 9499425
43. Denamur E, Bocquet N, Mougenot B, Da Silva F, Martinat L, Loirat C, Elion J, Bensman A, Ronco PM (1999) Mother-to-child transmitted WT1 splice-site mutation is responsible for distinct glomerular diseases. J Am Soc Nephrol 10:2219-2223. 1:STN:280:DyaK1MvjtlGiuw%3D%3D, 10505700
44. Demmer L, Primack W, Loik V, Brown R, Therville N, McElreavey K (1999) Frasier syndrome: A cause of focal segmental glomerulosclerosis in a 46,XX female. J Am Soc Nephrol 10:2215-2218. 1:CAS:528:DyaK1MXms1yls70%3D, 10505699
45. Patrakka J, Ruotsalainen V, Reponen P, Qvist E, Laine J, Holmberg C, Tryggvason K, Jalanko H (2002) Recurrence of nephrotic syndrome in kidney grafts of patients with congenital nephrotic syndrome of the Finnish type: Role of nephrin. Transplantation 73:394-403. 10.1097/00007890-200202150-00013, 11884936
46. Flynn JT, Schulman SL, de Chadarevian JP, Dunn SP, Kaiser BA, Polinsky MS, Baluarte HJ (1992) Treatment of steroid-resistant post-transplant nephrotic syndrome with cyclophosphamide in a child with congenital nephrotic syndrome. Pediatr Nephrol 6:553-555. 1:STN:280:ByyC38blsVM%3D, 1482645
47. Laine J, Jalanko H, Holthöfer H, Krogerus L, Rapola J, Willebrand E von, Lautenschlager I, Salmela K, Holmberg C (1993) Post-transplantation nephrosis in congenital nephrotic syndrome of the Finnish type. Kidney Int 44:867-874. 1:STN:280:ByuD1c7msVU%3D, 8258963
48. Barayan S, Al-Akash S, Malekzadeh M, Marik JL, Cohen AH, Ettenger RB, Yadin O (2001) Immediate post-transplant nephrosis in a patient with congenital nephrotic syndrome. Pediatr Nephrol 16:547-549. 10.1007/s004670100613, 1:STN:280:DC%2BD38%2FitFyhtw%3D%3D, 11465801
49. Bertelli R, Ginevri F, Caridi G, Dagnino M, Sandrini S, Di Duca M, Emma F, Sanna-Cherchi S, Scolari F, Neri TM, Murer L, Massella L, Basile G, Rizzoni G, Perfumo F, Ghiggeri GM (2003) Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. Am J Kidney Dis 41:1314-1321. 10.1016/S0272-6386(03)00364-0, 1:CAS:528:DC%2BD3sXkvFOisLc%3D, 12776285
50. Billing H, Muller D, Ruf R, Lichtenberger A, Hildebrandt F, August C, Querfeld U, Haffner D (2004) NPHS2 mutation associated with recurrence of proteinuria after transplantation. Pediatr Nephrol 19:561-564. 10.1007/s00467-003-1408-6, 15015071
51. Carraro M, Caridi G, Bruschi M, Artero M, Bertelli R, Zennaro C, Musante L, Candiano G, Perfumo F, Ghiggeri GM (2002) Serum glomerular permeability activity in patients with podocin mutations ( NPHS2 ) and steroid-resistant nephrotic syndrome. J Am Soc Nephrol 13:1946-1952. 1:CAS:528:DC%2BD38XlvVSqtL4%3D, 12089392